Triclosan - an update

The discovery in 1998 that triclosan has a site-specific action in the bacterial cell as an inhibitor of NADH- or NADPH-dependent enoyl-acyl carrier protein reductase led to a lively debate in the scientific press. The thesis of this debate was that such a mode of action may allow triclosan to induc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Letters in applied microbiology 2011-02, Vol.52 (2), p.87-95
Hauptverfasser: Saleh, S, Haddadin, R.N.S, Baillie, S, Collier, P.J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 95
container_issue 2
container_start_page 87
container_title Letters in applied microbiology
container_volume 52
creator Saleh, S
Haddadin, R.N.S
Baillie, S
Collier, P.J
description The discovery in 1998 that triclosan has a site-specific action in the bacterial cell as an inhibitor of NADH- or NADPH-dependent enoyl-acyl carrier protein reductase led to a lively debate in the scientific press. The thesis of this debate was that such a mode of action may allow triclosan to induce resistance and cross-resistance in bacterial cells. The debate last saw review in 2004, and this paper aims at updating our knowledge in this area, given recent research on the topic.
doi_str_mv 10.1111/j.1472-765X.2010.02976.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_879471380</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>879471380</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5046-5576e9f9f1550a6680f8abf3cd9e3691832a312e0f23441cf521d1ff20b117243</originalsourceid><addsrcrecordid>eNqNkL1PAjEchhujEURHV2UxTof99fM6OBDiV4JxEBK3pty15sjBYctF-O_teYijdmib9nnfNg9CfcADiONmPgAmSSIFfxsQHE8xUVIMNgeou784RF1MhEhSwlkHnYQwxxinQNQx6hAAIVIKXXQ-8UVWVsEs-0k_TvUqN2t7io6cKYM92609NL2_m4wek_HLw9NoOE4yjplIOJfCKqcccI5NbMQuNTNHs1xZKhSklBgKxGJHKGOQOU4gB-cIngFIwmgPXbe9K1991Das9aIImS1Ls7RVHXQqFZNAU_w3SXmsFEJGMm3JzFcheOv0yhcL47casG7s6bluJOlGkm7s6W97ehOjF7tH6tnC5vvgj64IXO0AEzJTOm-WWRF-OSopjmzkblvusyjt9t8f0OPhc7OL-cs270ylzbuPb0xfIxnbFcWcSfoFx9aP6Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>835117667</pqid></control><display><type>article</type><title>Triclosan - an update</title><source>Wiley Online Library - AutoHoldings Journals</source><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Saleh, S ; Haddadin, R.N.S ; Baillie, S ; Collier, P.J</creator><creatorcontrib>Saleh, S ; Haddadin, R.N.S ; Baillie, S ; Collier, P.J</creatorcontrib><description>The discovery in 1998 that triclosan has a site-specific action in the bacterial cell as an inhibitor of NADH- or NADPH-dependent enoyl-acyl carrier protein reductase led to a lively debate in the scientific press. The thesis of this debate was that such a mode of action may allow triclosan to induce resistance and cross-resistance in bacterial cells. The debate last saw review in 2004, and this paper aims at updating our knowledge in this area, given recent research on the topic.</description><identifier>ISSN: 0266-8254</identifier><identifier>EISSN: 1472-765X</identifier><identifier>DOI: 10.1111/j.1472-765X.2010.02976.x</identifier><identifier>PMID: 21166831</identifier><identifier>CODEN: LAMIE7</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>antibiotics ; antimicrobials ; biocides ; Biological and medical sciences ; Disinfectants - chemistry ; Disinfectants - pharmacology ; Drug Resistance, Bacterial ; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH) - antagonists &amp; inhibitors ; Enzyme Inhibitors - chemistry ; Enzyme Inhibitors - pharmacology ; Fatty Acid Synthesis Inhibitors - chemistry ; Fatty Acid Synthesis Inhibitors - pharmacology ; Fundamental and applied biological sciences. Psychology ; mechanism of action ; Microbiology ; resistance ; Triclosan - chemistry ; Triclosan - pharmacology</subject><ispartof>Letters in applied microbiology, 2011-02, Vol.52 (2), p.87-95</ispartof><rights>2010 The Authors. Letters in Applied Microbiology © 2010 The Society for Applied Microbiology</rights><rights>2015 INIST-CNRS</rights><rights>2010 The Authors. Letters in Applied Microbiology © 2010 The Society for Applied Microbiology.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5046-5576e9f9f1550a6680f8abf3cd9e3691832a312e0f23441cf521d1ff20b117243</citedby><cites>FETCH-LOGICAL-c5046-5576e9f9f1550a6680f8abf3cd9e3691832a312e0f23441cf521d1ff20b117243</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1472-765X.2010.02976.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1472-765X.2010.02976.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27922,27923,45572,45573</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=23730116$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21166831$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Saleh, S</creatorcontrib><creatorcontrib>Haddadin, R.N.S</creatorcontrib><creatorcontrib>Baillie, S</creatorcontrib><creatorcontrib>Collier, P.J</creatorcontrib><title>Triclosan - an update</title><title>Letters in applied microbiology</title><addtitle>Lett Appl Microbiol</addtitle><description>The discovery in 1998 that triclosan has a site-specific action in the bacterial cell as an inhibitor of NADH- or NADPH-dependent enoyl-acyl carrier protein reductase led to a lively debate in the scientific press. The thesis of this debate was that such a mode of action may allow triclosan to induce resistance and cross-resistance in bacterial cells. The debate last saw review in 2004, and this paper aims at updating our knowledge in this area, given recent research on the topic.</description><subject>antibiotics</subject><subject>antimicrobials</subject><subject>biocides</subject><subject>Biological and medical sciences</subject><subject>Disinfectants - chemistry</subject><subject>Disinfectants - pharmacology</subject><subject>Drug Resistance, Bacterial</subject><subject>Enoyl-(Acyl-Carrier-Protein) Reductase (NADH) - antagonists &amp; inhibitors</subject><subject>Enzyme Inhibitors - chemistry</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Fatty Acid Synthesis Inhibitors - chemistry</subject><subject>Fatty Acid Synthesis Inhibitors - pharmacology</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>mechanism of action</subject><subject>Microbiology</subject><subject>resistance</subject><subject>Triclosan - chemistry</subject><subject>Triclosan - pharmacology</subject><issn>0266-8254</issn><issn>1472-765X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkL1PAjEchhujEURHV2UxTof99fM6OBDiV4JxEBK3pty15sjBYctF-O_teYijdmib9nnfNg9CfcADiONmPgAmSSIFfxsQHE8xUVIMNgeou784RF1MhEhSwlkHnYQwxxinQNQx6hAAIVIKXXQ-8UVWVsEs-0k_TvUqN2t7io6cKYM92609NL2_m4wek_HLw9NoOE4yjplIOJfCKqcccI5NbMQuNTNHs1xZKhSklBgKxGJHKGOQOU4gB-cIngFIwmgPXbe9K1991Das9aIImS1Ls7RVHXQqFZNAU_w3SXmsFEJGMm3JzFcheOv0yhcL47casG7s6bluJOlGkm7s6W97ehOjF7tH6tnC5vvgj64IXO0AEzJTOm-WWRF-OSopjmzkblvusyjt9t8f0OPhc7OL-cs270ylzbuPb0xfIxnbFcWcSfoFx9aP6Q</recordid><startdate>201102</startdate><enddate>201102</enddate><creator>Saleh, S</creator><creator>Haddadin, R.N.S</creator><creator>Baillie, S</creator><creator>Collier, P.J</creator><general>Blackwell Publishing Ltd</general><general>Blackwell</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>201102</creationdate><title>Triclosan - an update</title><author>Saleh, S ; Haddadin, R.N.S ; Baillie, S ; Collier, P.J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5046-5576e9f9f1550a6680f8abf3cd9e3691832a312e0f23441cf521d1ff20b117243</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>antibiotics</topic><topic>antimicrobials</topic><topic>biocides</topic><topic>Biological and medical sciences</topic><topic>Disinfectants - chemistry</topic><topic>Disinfectants - pharmacology</topic><topic>Drug Resistance, Bacterial</topic><topic>Enoyl-(Acyl-Carrier-Protein) Reductase (NADH) - antagonists &amp; inhibitors</topic><topic>Enzyme Inhibitors - chemistry</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Fatty Acid Synthesis Inhibitors - chemistry</topic><topic>Fatty Acid Synthesis Inhibitors - pharmacology</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>mechanism of action</topic><topic>Microbiology</topic><topic>resistance</topic><topic>Triclosan - chemistry</topic><topic>Triclosan - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Saleh, S</creatorcontrib><creatorcontrib>Haddadin, R.N.S</creatorcontrib><creatorcontrib>Baillie, S</creatorcontrib><creatorcontrib>Collier, P.J</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Letters in applied microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Saleh, S</au><au>Haddadin, R.N.S</au><au>Baillie, S</au><au>Collier, P.J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Triclosan - an update</atitle><jtitle>Letters in applied microbiology</jtitle><addtitle>Lett Appl Microbiol</addtitle><date>2011-02</date><risdate>2011</risdate><volume>52</volume><issue>2</issue><spage>87</spage><epage>95</epage><pages>87-95</pages><issn>0266-8254</issn><eissn>1472-765X</eissn><coden>LAMIE7</coden><abstract>The discovery in 1998 that triclosan has a site-specific action in the bacterial cell as an inhibitor of NADH- or NADPH-dependent enoyl-acyl carrier protein reductase led to a lively debate in the scientific press. The thesis of this debate was that such a mode of action may allow triclosan to induce resistance and cross-resistance in bacterial cells. The debate last saw review in 2004, and this paper aims at updating our knowledge in this area, given recent research on the topic.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>21166831</pmid><doi>10.1111/j.1472-765X.2010.02976.x</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0266-8254
ispartof Letters in applied microbiology, 2011-02, Vol.52 (2), p.87-95
issn 0266-8254
1472-765X
language eng
recordid cdi_proquest_miscellaneous_879471380
source Wiley Online Library - AutoHoldings Journals; MEDLINE; Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects antibiotics
antimicrobials
biocides
Biological and medical sciences
Disinfectants - chemistry
Disinfectants - pharmacology
Drug Resistance, Bacterial
Enoyl-(Acyl-Carrier-Protein) Reductase (NADH) - antagonists & inhibitors
Enzyme Inhibitors - chemistry
Enzyme Inhibitors - pharmacology
Fatty Acid Synthesis Inhibitors - chemistry
Fatty Acid Synthesis Inhibitors - pharmacology
Fundamental and applied biological sciences. Psychology
mechanism of action
Microbiology
resistance
Triclosan - chemistry
Triclosan - pharmacology
title Triclosan - an update
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T01%3A26%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Triclosan%20-%20an%20update&rft.jtitle=Letters%20in%20applied%20microbiology&rft.au=Saleh,%20S&rft.date=2011-02&rft.volume=52&rft.issue=2&rft.spage=87&rft.epage=95&rft.pages=87-95&rft.issn=0266-8254&rft.eissn=1472-765X&rft.coden=LAMIE7&rft_id=info:doi/10.1111/j.1472-765X.2010.02976.x&rft_dat=%3Cproquest_cross%3E879471380%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=835117667&rft_id=info:pmid/21166831&rfr_iscdi=true